生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

交易中 12-19 10:40:23 EST

1,122.17

+22.50

+2.05%

最高1,122.35	最低1,099.66	成交量3.36亿
今开1,099.66	昨收1,099.66	日振幅2.06%
总市值0.00	流通市值0.00	总股本0.00
成交额63.20亿	换手率--	流通股本0.00
市净率7.038401	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1122.1654,"timestamp":1766158823318,"preClose":1099.6627,"halted":0,"volume":336318013,"delay":0,"changeRate":0.020463,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":22.502686,"latestTime":"12-19 10:40:23 EST","open":1099.6567,"high":1122.3485,"low":1099.6567,"amount":6320422372.052403,"amplitude":0.020635,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.038401,"peRate":-123.871822,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"2592252198","title":"热门中概股盘初上扬 纳斯达克中国金龙指数涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592252198","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592252198?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:43","pubTimestamp":1766155399,"startTime":"0","endTime":"0","summary":"金吾财讯 | 热门中概股盘初上扬，纳斯达克中国金龙指数涨0.84%。小马智行(PONY)涨7.01%，小鹏汽车(XPEV)涨6.10%，拼多多(PDD)涨5.82%，再鼎医药(ZLAB)涨3.73%，理想汽车(LI)涨3.71%，霸王茶姬(CHA)涨3.67%，禾赛(HSAI)涨3.52%，日月光半导体(ASX)涨2.29%。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/Nzk4YjI5MDc3NDg0OGUyMzM5MTA4ODUzNg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzk4YjI5MDc3NDg0OGUyMzM5MTA4ODUzNg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"295586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","LU0320764599.SGD","LU1719994722.HKD","LU0823413587.USD","IE00B3M56506.USD","BK4555","LU0633140727.USD","BK4509","LU2242644610.SGD","BK4503","LU0588546209.SGD","LU1323998911.USD","BK4553","HK0000320223.HKD","IE00BGV7N243.SGD","LU1048596156.SGD","EVS.SI","IE00B29SXG58.USD","LU0259732245.USD","BK4588","LU0683595622.HKD","BK4122","LU0823039010.USD","LU0359201612.USD","LU0039217434.USD","LU0871576103.HKD","BK4551","LU0048580855.USD","LU0328353924.USD","LU0359201885.HKD","LU1868837722.USD","LU0572944931.SGD","LU0823413660.USD","LU0708995583.HKD","LU0823038988.USD","LU0878005551.USD","LU1769817096.USD","BK4501","LU0348766576.USD","LU1171460220.USD","BK4139","LU1242518857.USD","LU0605514214.HKD","BK4563","LU2257852520.SGD","BK4023","LU0594300419.USD","LU0359202008.SGD","SG9999014674.SGD","LU0516422952.EUR","LU0049112450.USD","LU0307460666.USD","LU1868838027.USD","LU1956131251.USD","LU1961090484.USD","LU0164865239.USD","LU0589944569.HKD","LU0594300179.USD","LU2087589342.USD","BK4539","LU0315179316.USD","LU0456846285.SGD","LU0143863198.USD","SG9999002828.SGD","LU0823397103.USD","LU0348827113.USD","SG9999002562.SGD","LU0348767384.USD","LU2039709279.SGD","BK4558","LU0051755006.USD","LU1868837565.USD","LU2211817866.USD","LU0348788117.USD","LU1981816686.USD","LU0370786039.SGD","HK0000306685.HKD","LU0531971595.HKD","LU0348825331.USD","LU0821914370.USD","LU2264538146.SGD","LU0231483743.USD","LU0329678170.USD","HK0000306701.USD","LU0052750758.USD","LU0650527681.SGD","LU0417516902.SGD","LU0502904849.HKD","SG9999002463.SGD","LU1770034418.SGD","LU1988902786.USD","LU0117841782.USD","LU1880383366.USD","LU1808992512.USD","BK4585","LU1251922891.USD","LU2399975544.HKD","LU0072462343.USD","LU0737861772.HKD","LU1242518931.SGD","LU1794554557.SGD","IE00B0JY6N72.USD","BK4526","LU0456827905.SGD","LU0235996351.USD","BK4535","HK0000320264.USD","LU0516423174.USD","LU0455707207.USD","LU1235295612.USD","BK4505","LU0329678337.USD","LU0516422440.USD","LU1046422090.SGD","LU0140636845.USD","LU1769817179.HKD","LU0327786744.USD","LU0823397285.USD","LU0979878070.USD","LU1880383440.USD","LU0633140560.USD","BK4124","LU0516423091.SGD","LU0516422366.SGD","LU0823426308.USD","LU1720050803.USD","LU0561508036.HKD","LU1048588211.SGD","LU2488822045.USD","BK4099","IE0034224299.USD","LU1023057109.AUD","BK4220","LU0823426480.USD",".IXIC","BK4610","LU0143863784.USD","LU0047713382.USD","LU1303224171.USD","BK4504","BK4531","LU1064131342.USD","LU0210526637.USD","LU0348805143.USD"],"gpt_icon":0},{"id":"1112355521","title":"健永生技：未意识到有任何重要、未公开的价格敏感信息或企业动态来解释近期交易活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1112355521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112355521?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:05","pubTimestamp":1766153116,"startTime":"0","endTime":"0","summary":"健永生技：未意识到有任何重要、未公开的价格敏感信息或企业动态来解释近期交易活动","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1139406308","title":"健永生技有限公司：与一些有意购买公司普通股的投资基金进行洽谈","url":"https://stock-news.laohu8.com/highlight/detail?id=1139406308","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139406308?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:05","pubTimestamp":1766153113,"startTime":"0","endTime":"0","summary":"健永生技有限公司：与一些有意购买公司普通股的投资基金进行洽谈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1187502050","title":"拜玛林制药：根据合并协议终止，阿米库斯将支付拜玛林1.75亿美元的终止费用 - SEC提交文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1187502050","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187502050?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:52","pubTimestamp":1766152334,"startTime":"0","endTime":"0","summary":"拜玛林制药：根据合并协议终止，阿米库斯将支付拜玛林1.75亿美元的终止费用 - SEC提交文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD","BK4139","BMRN","IE00B19Z3B42.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"1191463279","title":"爱美医疗股价在盘前交易中上涨30%，拜玛林制药将以48亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1191463279","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191463279?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:13","pubTimestamp":1766149995,"startTime":"0","endTime":"0","summary":"爱美医疗股价在盘前交易中上涨30%，拜玛林制药将以48亿美元收购该公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRN","IE00B19Z3581.USD","LU2065171311.SGD","IE00B7SZLL34.SGD","BK4139","LU2065169927.USD","BK4566","LU2065170008.USD","LU2065171402.SGD","IE00B19Z3B42.SGD","FOLD","IE0002270589.USD"],"gpt_icon":0},{"id":"1131321261","title":"Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA 用于治疗复杂性尿路感染，包括肾盂肾炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1131321261","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131321261?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:06","pubTimestamp":1766149562,"startTime":"0","endTime":"0","summary":"Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA，用于治疗复杂性尿路感染，包括肾盂肾炎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO","BK4139"],"gpt_icon":0},{"id":"1198499096","title":"Galectin Therapeutics 发布FDA书面回复后的监管更新，并宣布Richard E. Uihlein提供额外1000万美元的信用额度，足以覆盖至2027年3月的预期支出","url":"https://stock-news.laohu8.com/highlight/detail?id=1198499096","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198499096?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:03","pubTimestamp":1766149396,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics 发布FDA书面回复后的监管更新，并宣布Richard E. Uihlein提供额外1000万美元的信用额度，足以覆盖至2027年3月的预期支出","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"1149514367","title":"IN8bio宣布私募融资定价，金额高达4020万美元，以推进新型伽马-δ T细胞连接剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1149514367","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149514367?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:01","pubTimestamp":1766149270,"startTime":"0","endTime":"0","summary":"IN8bio宣布私募融资定价，金额高达4020万美元，以推进新型伽马-δ T细胞连接剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"1174007364","title":"拜玛林制药以48亿美元收购爱美医疗，巩固稀有疾病领域的领导地位，推动收入增长，增强财务前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1174007364","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174007364?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:52","pubTimestamp":1766148765,"startTime":"0","endTime":"0","summary":"拜玛林制药以48亿美元收购爱美医疗，巩固稀有疾病领域的领导地位，推动收入增长，增强财务前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","IE00B7SZLL34.SGD","LU2065171402.SGD","IE00B19Z3B42.SGD","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4139","BMRN","IE00B19Z3581.USD","IE0002270589.USD","BK4566"],"gpt_icon":0},{"id":"1159090067","title":"爱美医疗将于2037年1月30日授予Aurobindo和Lupin在美国市场销售Galafold的仿制药许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1159090067","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159090067?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:52","pubTimestamp":1766148759,"startTime":"0","endTime":"0","summary":"爱美医疗将于2037年1月30日授予Aurobindo和Lupin在美国市场销售Galafold的仿制药许可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","IE00B7SZLL34.SGD","LU2065171402.SGD","IE00B19Z3B42.SGD","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4139","BMRN","IE00B19Z3581.USD","IE0002270589.USD","BK4566"],"gpt_icon":0},{"id":"1168785237","title":"爱美医疗：交易将于2027年开始显著提升拜玛林制药的非GAAP稀释每股收益","url":"https://stock-news.laohu8.com/highlight/detail?id=1168785237","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168785237?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:48","pubTimestamp":1766148494,"startTime":"0","endTime":"0","summary":"爱美医疗：交易将于2027年开始显著提升拜玛林制药的非GAAP稀释每股收益","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","LU2065171402.SGD","IE00B7SZLL34.SGD","BMRN","IE0002270589.USD","BK4566","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","IE00B19Z3581.USD","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"1181606810","title":"Evaxion Biotech A/S - 可获得最高达5.92亿美元的里程碑付款，以支持Evx-B3的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1181606810","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181606810?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:09","pubTimestamp":1766146191,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S - 可获得最高达5.92亿美元的里程碑付款，以支持Evx-B3的开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014567.USD","LU1929549753.HKD","SG9999001440.SGD","LU0203347892.USD","LU1061106388.HKD","LU1989771016.USD","LU1201861249.SGD","IE0009355771.USD","BK4588","SG9999014542.SGD","BK4534","LU0203345920.USD","LU1093756168.USD","LU1917777945.USD","LU2125154935.USD","LU2461242641.AUD","LU1699723380.USD","LU2468319806.SGD","BK4007","LU2361044949.HKD","LU2125154778.USD","LU0234572021.USD","SG9999015341.SGD","LU0861579265.USD","LU0070302665.USD","EVAX","IE00BFTCPJ56.SGD","LU0006306889.USD","LU1941712348.USD","LU0266013472.USD","LU2089984988.USD","LU0648001328.SGD","LU1941712264.USD","LU1585245621.USD","LU1430594728.SGD","LU1037948897.HKD","LU0477156953.USD","LU0265550946.USD","SG9999002224.SGD","BK4516","LU1934455277.USD","SG9999001176.USD","BK4550","LU0320765646.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0980610538.SGD","LU1989772923.USD","IE00BLSP4452.SGD","LU0965509283.SGD","LU0985320562.USD","LU1162221912.USD","LU1023059063.AUD","LU2324357040.USD","LU1116320737.USD","LU2361044865.SGD","LU1571399168.USD","IE00BN8TJ469.HKD","LU0130102774.USD","IE00BLSP4239.USD","BK4585","LU1035773651.USD","LU2361045086.USD","LU0098860793.USD","LU0965509010.AUD","LU0289739699.SGD","LU1057294990.SGD","LU1934455194.USD","LU1934455863.HKD","IE000M9KFDE8.USD","LU0965509101.SGD","LU0965508806.USD","LU0208291251.USD","LU0265550359.USD","LU0211331839.USD","IE00BSNM7G36.USD","LU1989772840.SGD","LU1116320901.HKD","LU2106854487.HKD","LU0122379950.USD","SGXZ57979304.SGD","LU1066051225.USD","LU1037948541.HKD","SG9999015358.SGD","LU0320765489.SGD","SG9999013999.USD","BK4559","LU0058720904.USD","IE00B1BXHZ80.USD","SG9999014559.SGD","BK4533","LU1093756325.SGD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","LU1066051498.USD","LU2023250843.SGD","BK4139","LU0130517989.USD","SG9999002232.USD","LU0106261372.USD","LU2112291526.USD","LU1974910355.USD","LU2360032135.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1291159041.SGD","SG9999001176.SGD","LU0238689110.USD","SG9999014575.USD","LU2023250504.SGD","LU1983299246.USD","LU1066051811.HKD","LU1069347547.HKD"],"gpt_icon":0},{"id":"1135275259","title":"Evaxion Biotech A/S保留Evx-B2全球权利并寻求其他潜在许可合作伙伴","url":"https://stock-news.laohu8.com/highlight/detail?id=1135275259","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135275259?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:09","pubTimestamp":1766146151,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S保留Evx-B2的全球权利，并计划寻找另一个潜在的许可合作伙伴。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"1122403977","title":"Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标","url":"https://stock-news.laohu8.com/highlight/detail?id=1122403977","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122403977?lang=zh_cn&edition=full","pubTime":"2025-12-19 19:31","pubTimestamp":1766143871,"startTime":"0","endTime":"0","summary":"Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4139","BK4599","LU1878469433.USD"],"gpt_icon":0},{"id":"2592344141","title":"RootData：ALT 将于一周后解锁价值约 269 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2592344141","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592344141?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:00","pubTimestamp":1766113209,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 12 月 26 日 8 时解锁约 24659 万枚代币，价值约 269 万美元。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2230980","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"1197058561","title":"Ra Capital Management, L.p.于12月11日报告持有Ovid Therapeutics 9.9%的被动股份 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197058561","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197058561?lang=zh_cn&edition=full","pubTime":"2025-12-19 07:12","pubTimestamp":1766099529,"startTime":"0","endTime":"0","summary":"Ra Capital Management, L.p.于12月11日报告持有Ovid Therapeutics 9.9%的被动股份 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"1156300410","title":"ETHZilla Corporation 提交可能的股份重新出售或其他处置申请，出售股东最多可出售 270 万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1156300410","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156300410?lang=zh_cn&edition=full","pubTime":"2025-12-19 06:24","pubTimestamp":1766096643,"startTime":"0","endTime":"0","summary":"ETHZilla Corporation 提交可能的股份重新出售或其他处置申请，出售股东最多可出售 270 万股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ETHZ"],"gpt_icon":0},{"id":"1142235368","title":"Arcus Biosciences Inc - 首次修正案将到期日延长至2030年9月1日，且不再有进一步延长权利 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1142235368","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142235368?lang=zh_cn&edition=full","pubTime":"2025-12-19 05:23","pubTimestamp":1766093017,"startTime":"0","endTime":"0","summary":"Arcus Biosciences Inc - 首次修正案将到期日延长至2030年9月1日，且不再有进一步延长权利 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"1158200264","title":"新闻稿：Crescent Biopharma公布诱导奖励授予情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1158200264","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158200264?lang=zh_cn&edition=full","pubTime":"2025-12-19 05:18","pubTimestamp":1766092728,"startTime":"0","endTime":"0","summary":"马萨诸塞州沃尔瑟姆，2025年12月18日-- Crescent Biopharma, Inc.，一家致力于快速推进癌症患者下一波治疗方案的生物技术公司，今天宣布其独立董事会批准向三名非执行员工授予总计129,626股公司普通股的期权作为《Crescent Biopharma, Inc. 2025就业诱导激励奖励计划》下的股权诱导奖励。该期权于2025年12月13日批准，2025年12月15日授予，并且对于每位员工接受Crescent的工作至关重要，符合纳斯达克上市规则5635。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"1133735395","title":"vTv Therapeutics和M42的Iros宣布向阿联酋卫生部提交Cadisegliatin用于2型糖尿病的二期临床研究方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1133735395","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133735395?lang=zh_cn&edition=full","pubTime":"2025-12-19 05:09","pubTimestamp":1766092153,"startTime":"0","endTime":"0","summary":"vTv Therapeutics和M42的Iros宣布向阿联酋卫生部提交Cadisegliatin用于2型糖尿病的二期临床研究方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTVT","BK4139"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}